Investors sold shares of McKesson Co. (NYSE:MCK) on strength during trading on Tuesday. $38.91 million flowed into the stock on the tick-up and $103.18 million flowed out of the stock on the tick-down, for a money net flow of $64.27 million out of the stock. Of all companies tracked, McKesson had the 0th highest net out-flow for the day. McKesson traded up $0.74 for the day and closed at $154.55
A number of equities research analysts recently weighed in on MCK shares. Royal Bank of Canada started coverage on shares of McKesson in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $168.00 price objective for the company. Jefferies Group set a $165.00 price objective on shares of McKesson and gave the company a “hold” rating in a research report on Wednesday, October 18th. Cowen raised shares of McKesson from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $176.00 to $189.00 in a research report on Tuesday, October 10th. Needham & Company LLC set a $179.00 price objective on shares of McKesson and gave the company a “buy” rating in a research report on Monday, October 16th. Finally, BidaskClub downgraded shares of McKesson from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 19th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company’s stock. McKesson presently has an average rating of “Buy” and an average price target of $174.31.
The company has a quick ratio of 0.61, a current ratio of 1.05 and a debt-to-equity ratio of 0.66. The company has a market cap of $32,219.73, a PE ratio of 12.71, a P/E/G ratio of 1.58 and a beta of 1.23.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.88%. The ex-dividend date is Thursday, November 30th. McKesson’s dividend payout ratio (DPR) is 6.45%.
In other news, CEO John H. Hammergren sold 99,000 shares of the stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $153.89, for a total value of $15,235,110.00. Following the completion of the transaction, the chief executive officer now directly owns 165,000 shares in the company, valued at $25,391,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO John H. Hammergren sold 100,000 shares of the stock in a transaction that occurred on Wednesday, September 27th. The shares were sold at an average price of $155.30, for a total transaction of $15,530,000.00. Following the completion of the transaction, the chief executive officer now owns 165,000 shares of the company’s stock, valued at $25,624,500. The disclosure for this sale can be found here. In the last 90 days, insiders sold 949,000 shares of company stock valued at $145,263,360. 1.20% of the stock is owned by insiders.
Institutional investors have recently bought and sold shares of the company. IHT Wealth Management LLC boosted its holdings in shares of McKesson by 64.2% in the second quarter. IHT Wealth Management LLC now owns 486 shares of the company’s stock valued at $1,027,000 after acquiring an additional 190 shares in the last quarter. Captrust Financial Advisors bought a new position in shares of McKesson in the second quarter valued at approximately $107,000. Harvest Fund Management Co. Ltd bought a new position in shares of McKesson in the second quarter valued at approximately $125,000. WFG Advisors LP boosted its holdings in shares of McKesson by 5.0% in the second quarter. WFG Advisors LP now owns 859 shares of the company’s stock valued at $141,000 after acquiring an additional 41 shares in the last quarter. Finally, Atwood & Palmer Inc. bought a new position in shares of McKesson in the second quarter valued at approximately $165,000. Institutional investors and hedge funds own 88.10% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Investors Sell McKesson (MCK) on Strength (MCK)” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://sportsperspectives.com/2017/12/14/investors-sell-mckesson-mck-on-strength-mck.html.
McKesson Company Profile
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.